ResFinder 4.0 for predictions of phenotypes from genotypes
By Valeria Bortolaia, R. Kaas, E. Ruppé, M. Roberts, S. Schwarz, V. Cattoir, A. Philippon, R. Allesøe, A. R. Rebelo, Alfred Ferrer Florensa and 25 more. Journal of Antimicrobial Chemotherapy, 2020
2,844 citations recorded by the source corpus.
Abstract Objectives WGS-based antimicrobial susceptibility testing (AST) is as reliable as phenotypic AST for several antimicrobial/bacterial species combinations. However, routine use of WGS-based AST is hindered by the need for bioinformatics skills and knowledge of antimicrobial resistance (AMR) determinants to operate the vast majority of tools developed to date. By leveraging on ResFinder and PointFinder, two freely accessible tools that can also assist users without bioinformatics skills, we aimed at increasing their speed and providing an easily interpretable antibiogram as output. Methods The ResFinder code was re-written to process raw reads and use Kmer-based alignment. The existing ResFinder and PointFinder databases were revised and expanded. Additional databases were developed including a genotype-to-phenotype key associating each AMR determinant with a phenotype at the antimicrobial compound level, and species-specific panels for in silico antibiograms. ResFinder 4.0 was validated using Escherichia coli (n = 584), Salmonella spp. (n = 1081), Campylobacter jejuni (n = 239), Enterococcus faecium (n = 106), Enterococcus faecalis (n = 50) and Staphylococcus aureus (n = 163) exhibiting different AST profiles, and from different human and animal sources and geographical origins. Results Genotype–phenotype concordance was ≥95% for 46/51 and 25/32 of the antimicrobial/species combinations evaluated for Gram-negative and Gram-positive bacteria, respectively. When genotype–phenotype concordance was <95%, discrepancies were mainly linked to criteria for interpretation of phenotypic tests and suboptimal sequence quality, and not to ResFinder 4.0 performance. Conclusions WGS-based AST using ResFinder 4.0 provides in silico antibiograms as reliable as those obtained by phenotypic AST at least for the bacterial species/antimicrobial agents of major public health relevance considered.
Subfields: Clinical Biochemistry, Molecular Medicine, Pollution
View Paper: https://www.semanticscholar.org/paper/c5a3be735cfcf83b6337bbb62c43433f2d9f4edc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Biochemistry
In Molecular Medicine
- Philip Thomas Lanken Conradsen Clausen
- Frank Moller Aarestrup
- R. Kaas
- Alfred Ferrer Florensa
- Derya Aytan-Aktug
Citations in the corpus
- ResFinder – an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes (2022, methodology): “The first versions of ResFinder were written in Perl and used blast [29] for aligning input sequences against the ResFinder database of ARGs [23].”
- Artificial Intelligence For Natural Product Drug Discovery (2023, methodology): “Numerous antimicrobial resistance determinant databases are available, such as the Comprehensive Antibiotic Resistance Database (CARD) 74 , a National Database of Antibiotic Resistant Organisms (NDARO) and ResFinder 75 .”